SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

IPCA Laboratories receives USFDA acceptance for formulations manufacturing unit in MP

04 Sep 2013 Evaluate

IPCA Laboratories has received the US Food and Drug Administration (USFDA) acceptance for its oral solid dosage formulations manufacturing facility situated at Pharmazone, SEZ Indore, Pithampur in state of Madhya Pradesh. This will enable the company to commercialize oral solid dosage formulations in the US market from this formulations manufacturing facility.

Last year in November, the company had decided that it will not manufacture any dosage formulations at its oral solid dosage formulations manufacturing facility and the dosage will not be commercialized for the US market. The company had taken this step as during the course of the internal quality assurance review it had noticed a few non-conformances at the said manufacturing unit. The company had voluntarily referred these to the USFDA and the same was under discussion with them for an appropriate resolution.

IPCA Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. It operates in 110 countries and its export accounts for 50% of the company’s income. Worldwide the company is one of the largest suppliers of APIs and intermediates. The company holds leadership position in Anti-malarial and Rheumatoid Arthritis area.

Ipca Laboratories Share Price

1551.75 -6.15 (-0.39%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×